{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T08:25:23Z","timestamp":1764318323202,"version":"3.46.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clim.2025.110613","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T23:18:44Z","timestamp":1760656724000},"page":"110613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Innate immune response to bacterial infections in hospitalized glucose-6-phosphate dehydrogenase-deficient patients; diagnostic value of white blood cell count"],"prefix":"10.1016","volume":"282","author":[{"given":"Islam M.","family":"Ghazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed F.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wasim S.","family":"El Nekidy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gehan","family":"Harb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diaa","family":"Alrahmany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2025.110613_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101363","article-title":"Impaired inflammasome activation and bacterial clearance in G6PD deficiency due to defective NOX\/p38 MAPK\/AP-1 redox signaling","volume":"28","author":"Yen","year":"2020","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.clim.2025.110613_bb0010","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00277-021-04395-1","article-title":"G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?","volume":"100","author":"Youssef","year":"2021","journal-title":"Ann. Hematol."},{"issue":"2","key":"10.1016\/j.clim.2025.110613_bb0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000453397","article-title":"Cellular innate immunity: an old game with new players","volume":"9","author":"Gasteiger","year":"2017","journal-title":"J. Innate Immun."},{"issue":"1","key":"10.1016\/j.clim.2025.110613_bb0020","first-page":"20","article-title":"Does a high WBC count signal infection?","volume":"35","author":"George","year":"2005"},{"issue":"1","key":"10.1016\/j.clim.2025.110613_bb0025","first-page":"1","article-title":"Correlation of serum C-reactive protein, white blood count and neutrophil percentage with histopathology findings in acute appendicitis","volume":"7","author":"Xharra","year":"2012"},{"key":"10.1016\/j.clim.2025.110613_bb0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijid.2020.09.017","article-title":"Association of baseline white blood cell counts with tuberculosis treatment outcome: a prospective multicentered cohort study","volume":"100","author":"Chedid","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.clim.2025.110613_bb0035","first-page":"819","article-title":"The clinical and prognostic importance of positive blood cultures in adults","volume":"123","author":"Pien","year":"2010"},{"article-title":"Segmentation of leukocyte cells in bone marrow smears","year":"2010","series-title":"2010 IEEE 23rd International Symposium on Computer-Based Medical Systems (CBMS)","key":"10.1016\/j.clim.2025.110613_bb0040"},{"key":"10.1016\/j.clim.2025.110613_bb0045","first-page":"264","article-title":"Changes in red blood cell membrane structure in G6PD deficiency: An atomic force microscopy study","volume":"444","author":"Tang","year":"2015"},{"issue":"1","key":"10.1016\/j.clim.2025.110613_bb0050","first-page":"211","article-title":"%J Annual review of medicine. Thalassemia: pathophysiology of red cell changes","volume":"45","author":"Schrier","year":"1994"},{"key":"10.1016\/j.clim.2025.110613_bb0055","first-page":"201","article-title":"Mechanisms and clinical complications of hemolysis in sickle cell disease and thalassemia","volume":"2","author":"Kato","year":"2009"},{"key":"10.1016\/j.clim.2025.110613_bb0060","volume":"92(4):818","author":"Bancone","year":"2015","journal-title":"Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests."},{"issue":"9","key":"10.1016\/j.clim.2025.110613_bb0065","first-page":"4514","article-title":"Dosage compensation in females with X-linked metabolic disorders","volume":"22","author":"Juchniewicz","year":"2021"},{"issue":"4","key":"10.1016\/j.clim.2025.110613_bb0070","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/10715762.2020.1866757","article-title":"G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19)","volume":"55","author":"Yang","year":"2021","journal-title":"Free Radic. Res."},{"issue":"7","key":"10.1016\/j.clim.2025.110613_bb0075","article-title":"Infections in G6PD-deficient hospitalized patients-prevalence, risk factors, and related mortality","volume":"11","author":"Alrahmany","year":"2022","journal-title":"Antibiotics (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.clim.2025.110613_bb0080","first-page":"34","article-title":"Glucose-6-phosphate dehydrogenase deficiency (G6PD) as a risk factor of male neonatal sepsis","volume":"9","author":"Rostami-Far","year":"2016","journal-title":"J. Med. Life"},{"issue":"1","key":"10.1016\/j.clim.2025.110613_bb0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bjh.16366","article-title":"Laboratory diagnosis of G6PD deficiency. A British Society for Haematology guideline","volume":"189","author":"Roper","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.clim.2025.110613_bb0090","first-page":"27","article-title":"Glucose-6-phosphate dehydrogenase laboratory assay: How, when, and why?","volume":"61","author":"Minucci","year":"2009"},{"key":"10.1016\/j.clim.2025.110613_bb0095","doi-asserted-by":"crossref","unstructured":"Au TY, Wi\u015bniewski OW, Benjamin S, Kubicki T, Dytfeld D, Gil LJAoH. G6PD deficiency\u2014does it alter the course of COVID-19 infections? 2023:1\u20138.","DOI":"10.1007\/s00277-023-05164-y"},{"issue":"16","key":"10.1016\/j.clim.2025.110613_bb0100","first-page":"1307","article-title":"COVID-19 in G6PD-deficient patients, oxidative stress, and neuropathology","volume":"22","author":"Hern\u00e1ndez-Ochoa","year":"2022"},{"issue":"1","key":"10.1016\/j.clim.2025.110613_bb0105","first-page":"87","article-title":"Cytokine responses of TNF-\u03b1, IL-6, and IL-10 in G6PD-deficient infants","volume":"31","author":"Liao","year":"2014"},{"issue":"7","key":"10.1016\/j.clim.2025.110613_bb0110","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ajem.2019.11.030","article-title":"Added value of inflammatory markers to vital signs to predict mortality in patients suspected of severe infection","volume":"38","author":"Takada","year":"2020","journal-title":"Am. J. Emerg. Med."},{"issue":"4","key":"10.1016\/j.clim.2025.110613_bb0115","first-page":"331","article-title":"Glucose-6-phosphate dehydrogenase deficiency with recurrent infections: case report","volume":"77","author":"Rosa-Borges","year":"2001"},{"issue":"10","key":"10.1016\/j.clim.2025.110613_bb0120","first-page":"312","article-title":"The brief case: recurrent Chromobacterium violaceum bloodstream infection in a glucose-6-phosphate dehydrogenase (G6PD)-deficient patient with a severe neutrophil defect","volume":"58","author":"Thwe","year":"2020","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.clim.2025.110613_bb0125","first-page":"212","article-title":"Severe glucose-6-phosphate dehydrogenase deficiency leads to susceptibility to infection and absent NETosis","volume":"139","author":"Siler","year":"2017"},{"key":"10.1016\/j.clim.2025.110613_bb0130","first-page":"4","article-title":"Overview of Infections in the Immunocompromised Host","volume":"4","author":"Dropulic","year":"2016"},{"issue":"2","key":"10.1016\/j.clim.2025.110613_bb0135","article-title":"Relationship between glucose-6-phosphate dehydrogenase deficiency, X-chromosome inactivation and inflammatory markers","volume":"12","author":"Errigo","year":"2023","journal-title":"Antioxidants (Basel, Switzerland)"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625001883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625001883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T08:20:21Z","timestamp":1764318021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661625001883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":27,"alternative-id":["S1521661625001883"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2025.110613","relation":{},"ISSN":["1521-6616"],"issn-type":[{"type":"print","value":"1521-6616"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innate immune response to bacterial infections in hospitalized glucose-6-phosphate dehydrogenase-deficient patients; diagnostic value of white blood cell count","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2025.110613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110613"}}